Bharat in BetaBiomanufacturing scale-up infrastructure
Source
- Ankur Capital, India's BioEconomy Roadmap 2035 commentary (opens in a new tab)BioX Foundry; commercialisationPublished: 28 Aug 2026
The idea
Bridge laboratory output and commercial production.
Why this is interesting
- The commentary names the step between a laboratory result and commercial production, along with limited manufacturing infrastructure, as a bottleneck. That step is where biology-based ventures need equipment, process expertise and capital at the same time.
- The source is Ankur Capital’s commentary on a government bioeconomy roadmap. A roadmap mission is a policy intention, not funded or proven demand, and the underlying roadmap was not separately reviewed here.
Possible starting points
Shared pilot-scale capacity
Find out whether teams at a similar stage would book shared pilot fermentation or processing time, and on what terms.
Scale-up process services
Offer process transfer and troubleshooting to teams moving from laboratory to pilot scale.
Questions to answer
- How many teams need the same equipment at the same time, and can a shared facility schedule them fairly?
- Does a customer pay for capacity, expertise or a guaranteed outcome?